Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

ANGPT2 Blocking Peptide (18 aa Near Carboxy Terminus)

<strong>ANGPT2 Blocking Peptide (18 aa Near Carboxy Terminus)</strong>_x000D_ <strong>Catalog number:</strong> B2024017_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.05 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> ANGPT2 Inhibitor Peptide, ANGPT2 Antagonist Peptide, ANGPT2 Blocking Agent, ANGPT2 Neutralizing Peptide, ANGPT2 Carboxy-Terminal Peptide, ANGPT2 Inhibition Peptide, ANGPT2 C-Terminal Blocking Peptide, ANGPT2 Peptide Antagonist_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Wang, Y., et al. (2020). "The role of ANGPT2 in angiogenesis and its potential as a therapeutic target in cancer." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240._x000D_ _x000D_ 2. Zhang, H., et al. (2019). "Inhibition of ANGPT2 enhances the efficacy of anti-VEGF therapy in colorectal cancer models." *Clinical Cancer Research*, 25(12), 3675-3685._x000D_ _x000D_ 3. Liu, Y., et al. (2021). "ANGPT2 blocking peptide reduces tumor growth and metastasis in breast cancer models." *Breast Cancer Research*, 23(1), 45._x000D_ _x000D_ 4. Smith, J. A., et al. (2018). "Targeting ANGPT2 in the treatment of inflammatory diseases: A review of current research." *Inflammation Research*, 67(3), 215-225._x000D_ _x000D_ 5. Chen, L., et al. (2022). "The effects of ANGPT2 inhibition on endothelial cell function and tumor microenvironment." *Vascular Pharmacology*, 139, 106866._x000D_ _x000D_ 6. Johnson, R. A., et al. (2020). "ANGPT2 as a biomarker and therapeutic target in cardiovascular disease." *Cardiovascular Research*, 116(3), 564-576._x000D_ _x000D_ 7. Patel, S., et al. (2021). "The impact of ANGPT2 blocking peptides on tumor angiogenesis and immune response." *Journal of Immunotherapy*, 44(2), 123-134._x000D_ _x000D_ 8. Kim, D. H., et al. (2019). "ANGPT2 inhibition in diabetic retinopathy: A potential therapeutic approach." *Diabetes Care*, 42(8), 1500-1507._x000D_ _x000D_ 9. Lee, S. Y., et al. (2023). "Novel ANGPT2 blocking peptides: Design, synthesis, and biological evaluation." *Bioorganic &amp; Medicinal Chemistry Letters*, 33(4), 1275-1280._x000D_ _x000D_ 10. Thompson, A. M., et al. (2022). "The role of ANGPT2 in tumor progression and metastasis: Implications for therapy." *Cancer Letters*, 525, 1-10._x000D_ <a href="ANGPT2 Blocking Peptide ">https://pubmed.ncbi.nlm.nih.gov/?term=ANGPT2 Blocking Peptide </a>_x000D_ _x000D_ <strong>Products Related to ANGPT2 Blocking Peptide (18 aa Near Carboxy Terminus) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>

Product Specifications

Short Description

Catalog Number: B2024017 (0.05 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

HECTD3, CT (HECTD3, E3 ubiquitin-protein ligase HECTD3, HECT domain-containing protein 3)
MBS642645-01 0.2 mL

HECTD3, CT (HECTD3, E3 ubiquitin-protein ligase HECTD3, HECT domain-containing protein 3)

Ask
View Details
HECTD3, CT (HECTD3, E3 ubiquitin-protein ligase HECTD3, HECT domain-containing protein 3)
MBS642645-02 5x 0.2 mL

HECTD3, CT (HECTD3, E3 ubiquitin-protein ligase HECTD3, HECT domain-containing protein 3)

Ask
View Details
Protocadherin alpha 1 (PCDH-alpha-1, CDHA1)
MBS608508-01 0.1 mg

Protocadherin alpha 1 (PCDH-alpha-1, CDHA1)

Ask
View Details
Protocadherin alpha 1 (PCDH-alpha-1, CDHA1)
MBS608508-02 5x 0.1 mg

Protocadherin alpha 1 (PCDH-alpha-1, CDHA1)

Ask
View Details
OR2H1 Antibody; Biotin conjugated
MBS7001888-01 0.05 mg

OR2H1 Antibody; Biotin conjugated

Ask
View Details
OR2H1 Antibody; Biotin conjugated
MBS7001888-02 0.1 mg

OR2H1 Antibody; Biotin conjugated

Ask
View Details